TUMOR INFILTRATING LYMPHOCYTES PECULIARITIES IN DIFFERENT HISTOPATHOLOGICAL AND MOLECULAR SUBTYPES OF GASTRIC

N Museridze1, A Tutisani1, G Chabradze1

  • 1Tbilisi Medical Academy Named After P. Shotadze.

Georgian Medical News
|August 8, 2021
PubMed

Insights

Tumor infiltrating lymphocytes (TILs) vary across gastric cancer subtypes. High TILs correlate with p53 mutations, offering potential for novel immunotherapeutic strategies in gastric carcinoma treatment.

Area of Science:

  • Oncology
  • Immunology
  • Gastroenterology

Background:

  • Gastric carcinoma is a leading cause of cancer mortality globally.
  • Immunotherapy offers promise for gastric cancer treatment, but patient response varies.
  • Tumor infiltrating lymphocytes (TILs) are key biomarkers, but their role in diverse gastric cancers needs characterization.

Purpose of the Study:

  • To characterize the TILs profile across different histopathological and molecular subtypes of gastric carcinomas.
  • To investigate the relationship between TILs and specific molecular markers in gastric cancer.

Main Methods:

  • Standard hematoxylin and eosin (H&E) staining for TIL evaluation.
  • Immunohistochemistry to detect CDH1, Ki67, p53, and Her2 expression.
  • Analysis of TILs in relation to histological and molecular subtypes.

Main Results:

  • TILs status significantly differs among gastric adenocarcinoma subtypes.
  • High TILs are significantly associated with p53 mutations in both enteric and diffuse types.
  • Variations in TILs may explain differing prognoses across gastric cancer subtypes.

Conclusions:

  • TILs exhibit distinct patterns in various gastric cancer subtypes, impacting prognosis.
  • The association between high TILs and p53 mutations presents a potential avenue for targeted immunotherapies.